Status Proposed
Process TAG


Key events during the development of the guidance:

Date Update
23 February 2018 The Department of Health has asked the Institute to conduct an appraisal of naldemedine for treating opioid-induced constipation which was due to start in mid-January 2018. We have been informed by the company of a delay to the licensing application, therefore, NICE will suspend and reschedule this appraisal in line with the new timings.

For further information on how we develop guidance, please see our page about NICE technology appraisal guidance